Blood & lymphatic cancer
12 articles shown
Thinking About Donating Stem Cells After Your Own Cancer History — How Peripheral Blood Collection Differs From Marrow Harvest, and Why Some Donors Need a Catheter Below the Collarbone
A plain-language guide for anyone considering hematopoietic stem cell donation: why peripheral blood collection and marrow harvest are two different routes, why some donors need a temporary central venous catheter below the collarbone and what that feels like, which side effects are commonly reported, and how a personal cancer history, age limits, and anemia are handled during eligibility screening.
When you can't eat well and keep feeling dizzy, and going to the hospital alone worries you — understanding the many causes of dizziness and how to travel safely
Why dizziness is common during cancer treatment — dehydration, orthostatic hypotension, anemia, and medications — plus warning signs that need urgent care and how to travel safely to appointments when you have no caregiver.
Radiation Before a Transplant: Understanding Total Body Irradiation (TBI) as Conditioning
The radiation given before a stem cell transplant, total body irradiation (TBI), is not a separate treatment but part of 'conditioning' that prepares the body for new cells. Here is why radiation, transplant, and the isolation room form one connected sequence.
My Own Immune Cells Catch the Cancer: CAR-T Therapy Made Simple
CAR-T cell therapy is a "living" immune treatment that takes the patient's own T cells, attaches an artificial receptor that recognizes cancer, and puts them back into the body. In blood cancers such as leukemia, lymphoma, and multiple myeloma, it can show dramatic effects in relapsed or refractory patients, but collecting cells, manufacturing them, and reinfusing them takes several weeks, and because of the possibility of cytokine release syndrome and neurological side effects, inpatient management at a specialized center is needed.
Transfusion During Chemotherapy: When and Why You Receive It, and What to Watch For
During chemotherapy, bone marrow function declines and anemia or low platelets are common, so you receive red blood cell or platelet transfusions based on both your counts and your symptoms. This piece calmly walks through the warning signs of a reaction in the early minutes of a transfusion, what to watch for in the days that follow, and the iron issue that can come with repeated transfusions, all from the patient's point of view.
GVHD After Transplant: Knowing the Skin, Gut, and Liver Signs in Advance Eases the Panic
This explains, at the patient's eye level, the early skin, gut, and liver symptoms of graft-versus-host disease (GVHD) that can arise after an allogeneic hematopoietic stem cell transplant. The key is knowing in advance about rash and itching on the hands and feet, diarrhea that will not stop and dehydration, and liver signs that show through like jaundice — and noting body changes around 100 days after transplant to tell the care team quickly.
One Pill a Day, a Lifelong Companion — How to Manage Targeted Therapy for Chronic Myeloid Leukemia
Targeted therapy (TKI) for chronic myeloid leukemia is a long-term medication, so a steady dosing habit largely decides treatment success. The keys are tying it to a fixed daily routine, following each drug's food and grapefruit precautions, and adjusting with your care team rather than stopping on your own when side effects appear. Regular gene testing tracks the response, and stopping treatment may be carefully considered when the conditions are met.
R-CHOP Chemotherapy for Lymphoma: The Five Drugs and How a Single Cycle Unfolds
A patient-friendly look at R-CHOP, the standard treatment for lymphoma. It explains the role of each of the five drugs (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone), how a single three-week cycle progresses, and the high-risk window around one week after treatment when fever and other warning signs deserve attention.
Hematopoietic Stem Cell Transplant: Following Along Step by Step, From Collection to Engraftment
This walks through the whole flow of a hematopoietic stem cell transplant in four stages—collection, conditioning, infusion, and engraftment. In everyday language it points out that the final transplant itself is as quiet as a blood transfusion, that there are tough hurdles before and after as the marrow is emptied and immunity bottoms out, and that engraftment—new cells settling in and making blood again—usually takes about two weeks.
CAR-T Cell Therapy: Which Blood Cancer Patients Is It For?
CAR-T cell therapy takes a patient's own immune cells (T cells), reengineers them to recognize cancer, and returns them to the body. It is used for some lymphoma, leukemia, and myeloma patients whose disease has relapsed despite several rounds of treatment, and managing its distinctive side effects, such as cytokine release, is central.
Multiple Myeloma: The Blood Cancer That Weakens Bone — Symptoms and the Path of Treatment
Multiple myeloma is a blood cancer in which plasma cells in the bone marrow multiply abnormally, weakening bone and causing anemia, kidney strain, and high calcium. Diagnosis combines blood and urine tests, a marrow biopsy, and imaging, and it is treated as a long-term disease using targeted drugs, immunomodulators, and stem cell transplant.
Lymphoma Staging and Prognostic Factors: Understanding the Numbers Without the Fear
The stage of a lymphoma is simply a map of how far the disease has spread through the body; it does not directly equal how dangerous things are. Staging runs from I to IV based on the diaphragm, with an A or B added depending on whether B symptoms are present, but the actual treatment plan is set by weighing prognostic factors such as age, LDH, and overall condition (the IPI) at the same time. Even stage IV can reach complete remission, and the meaning shifts dramatically depending on the cell type, so the key is not to be overwhelmed by the number but to talk it through with your own doctor.